Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Tablet Health vs TeleFirst Med

Tablet Health
Graded #495

Lower grade

vs+9.799999999999997
TeleFirst Med
Graded #399

Higher grade

The verdict

TeleFirst Med takes it — 57.4/100 to 47.6/100.

TeleFirst Med grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. TeleFirst Med is a virtual urgent-care and primary-care telehealth clinic that also offers a GLP-1 weight-loss path: a $120 telehealth evaluation with a licensed doctor who, if you qualify, prescribes real…

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueEven
45
45
Dose & formulationTeleFirst Med +2
51
53
Clinical oversightTeleFirst Med +45
37
82
Labs & monitoringTeleFirst Med +2
50
52
FulfillmentTeleFirst Med +1
57
58
Contract termsEven
55
55
Tablet Health · left barTeleFirst Med · right bar

The numbers

MetricTablet HealthTeleFirst Med
WeighScore47.6/10057.4/100
GradeCC
Scorecard rank#495#399
SemaglutideNot disclosedNot disclosed
TirzepatideNot disclosedNot disclosed
CoverageCoverage not published2 states
Brand-name accessCompounded onlyYes
Oral / sublingualYesInjection only
Tablet Health

Graded #495 · C

Strengths

  • LegitScript Certified
  • Four named compounding pharmacy partners (Pharmacy Hub, Epiq Scripts, Dr. TelX, Emerad), none with FDA warning letters
  • Oral GLP-1 option for both semaglutide and tirzepatide — uncommon in compounded telehealth
  • Mid-tier pricing starting $179–$299/mo across all four product variants
  • No commitment — cancel anytime

Where it loses points

  • States served not published — you must complete the intake quiz to learn eligibility
  • No founder, CEO, medical director, or pharmacist-in-charge named anywhere
  • No BBB profile found
  • Its Queens NYC pharmacy is 'opening soon' — all dispensing currently routes through external partners
  • FDA issued this company a warning letter dated 19 March 2025; the letter is public in FDA's warning-letter database
TeleFirst Med

Graded #399 · C

Strengths

  • Prescribes real brand-name GLP-1 (e.g. Ozempic/Wegovy), not compounded — appealing if you specifically want FDA-approved branded medication
  • Simple $120 telehealth evaluation with a licensed doctor; no insurance hassle and no prior authorization
  • You fill the prescription at your own regular pharmacy rather than waiting on a mail-order compounding pharmacy
  • Also a general telehealth clinic (urgent care, chronic-condition management) if you want broader care

Where it loses points

  • Only Texas and North Carolina are confirmed — not available nationwide
  • The $120 is an evaluation fee; the brand-name medication is billed separately at your pharmacy and can be expensive without insurance
  • Small practice (about 500 patients) with limited public detail on its clinicians and program
  • No compounded or lower-cost medication option, and no medication pricing is published

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard